Inventor
JARRETT PETER
US25 patents
⚠️ This page may combine multiple inventors who share the name “JARRETT PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCEPT LLC
11 patentsUS8563027B2Oct 22, 2013
Drug delivery through hydrogel plugs
INCEPT LLC48 citations98
US9205150B2Dec 8, 2015
Medical organogel processes and compositions
INCEPT LLC50 citations97
US10905765B2Feb 2, 2021
Medical organogel processes and compositions
INCEPT LLC16 citations94
US10786462B2Sep 29, 2020
Shape changing drug delivery devices and methods
INCEPT LLC25 citations93
US10420724B2Sep 24, 2019
Shape changing drug delivery devices and methods
INCEPT LLC29 citations93
US10617563B2Apr 14, 2020
Coated implants
INCEPT LLC17 citations84
US11369591B2Jun 28, 2022
Drug delivery from hydrogels
INCEPT LLC5 citations72
US11890343B2Feb 6, 2024
Medical organogel processes and compositions
INCEPT LLC0 citations62
US11938223B2Mar 26, 2024
Shape changing drug delivery devices and methods
INCEPT LLC0 citations61
US11413250B2Aug 16, 2022
Shape changing drug delivery devices and methods
INCEPT LLC0 citations61
US12171869B2Dec 24, 2024
Intracameral drug delivery depots
INCEPT LLC0 citations50
OCULAR THERAPEUTIX INC
11 patentsUS11291627B1Apr 5, 2022
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine
OCULAR THERAPEUTIX INC6 citations84
US11534396B2Dec 27, 2022
Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor
OCULAR THERAPEUTIX INC9 citations83
US11439592B2Sep 13, 2022
Ocular implant containing a tyrosine kinase inhibitor
OCULAR THERAPEUTIX INC6 citations83
US11331267B2May 17, 2022
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine
OCULAR THERAPEUTIX INC5 citations83
US12357565B2Jul 15, 2025
Ocular implant containing a tyrosine kinase inhibitor
OCULAR THERAPEUTIX INC1 citations72
US12161753B2Dec 10, 2024
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent
OCULAR THERAPEUTIX INC2 citations72
US11779536B2Oct 10, 2023
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine
OCULAR THERAPEUTIX INC1 citations72
US12109302B2Oct 8, 2024
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine
OCULAR THERAPEUTIX INC0 citations61
US12023276B2Jul 2, 2024
Intracanalicular depot inserter device
OCULAR THERAPEUTIX INC1 citations54
US12453724B2Oct 28, 2025
Ocular implant containing a tyrosine kinase inhibitor
OCULAR THERAPEUTIX INC0 citations53
US12226341B2Feb 18, 2025
Implant injector device
OCULAR THERAPEUTIX INC0 citations45